---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-052719"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2025-05-27T23:59:59+00:00"
generated_at: "2026-05-20T11:16:35.612230+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# MindMed appoints Brandi Roberts as CFO effective June 2, 2025; inducement awards granted

## Summary
- Roberts previously CFO of Longboard Pharmaceuticals, led IPO and $2.6B Lundbeck acquisition.
- Base salary $495,000; eligible for annual cash bonus up to 40% of base salary.
- Inducement awards: option for 500,000 shares (4-year vest) and 125,000 PSUs (3-year vest, 0-200% payout).
- Roberts replaces Carrie Liao as principal financial and accounting officer effective June 2.

## SEC filing metadata
- accession: 0001104659-25-052719
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2025-05-27T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/tm2516110d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-052719
- JSON: https://secwatch.observer/filing/0001104659-25-052719.json
- Plain text: https://secwatch.observer/filing/0001104659-25-052719.txt

## Key facts
- Executive change
  Brandi L. Roberts was appointed as Chief Financial Officer at Definium Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: had appointed Brandi L. Roberts as Chief Financial Officer, effective as of June 2, 2025 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm
- Executive change
  Carrie Liao changed role as principal financial officer and principal accounting officer at Definium Therapeutics, Inc..
  - Action: will no longer serve as
  - Role: principal financial officer and principal accounting officer
  source text: Carrie Liao, the Company’s Chief Accounting Officer, will no longer serve as the Company’s principal financial officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.